0.244
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
60.19%
-14.97
|
-9.3438 | -13.80 | -10.61 | -9.7584 |
| Net Income/Loss |
67.71%
-14.56
|
-8.6806 | -13.03 | -9.6932 | -8.8275 |
| Basic Average Shares |
0.00%
95.18
|
95.18 | - | 95.19 | 95.19 |
| Diluted Average Shares |
0.00%
95.18
|
95.18 | - | 95.19 | 95.19 |
| Basic Earnings Per Share |
66.67%
-0.15
|
-0.09 | - | -0.10 | -0.09 |
| Diluted Earnings Per Share |
66.67%
-0.15
|
-0.09 | - | -0.10 | -0.09 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):